Patient experience with home‐based ocrelizumab treatment
Patients reported favorable scores across PRO measures of their at‐home infusion experience, compared to their prior infusion experience at an infusion center. Significant improvements from were reported following a home for overall experience with the at‐home infusion process (The (A) overall patient experience with ocrelizumab home infusion, (B) patient experience with nurses during home infusion and (C) patient preference for infusion location.